The Clinical Guidance document is an extensive and comprehensive reference aimed at clinicians and other practitioners across a range of clinical settings.
It provides detailed information and guidance on the acute and chronic harms of a range of club drugs and NPS and their management.
The guidance was developed out of a systematic review of the English language research evidence on the harms of a range of club drugs and NPS and their clinical management, based on systematic methods.
The guidance is also based on the critical appraisal of the literature reviewed, which is the process of examining research systematically to judge the quality and validity of research, how generalizable its findings are, and its relevance in a particular context. Where research evidence was lacking, consensus was sought from the multi-disciplinary NEPTUNE expert advisory group.
Click on the button to view the clinical guidance paper.Clinical Guidance paper